[Public Comment Submission] “Basic Plan for the Promotion of Cancer Control (Draft)” (February 18, 2023)
date : 2/27/2023
Tags: NCDs, Precision Cancer Medicine
![[Public Comment Submission] “Basic Plan for the Promotion of Cancer Control (Draft)” (February 18, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/pcm-20230218-top_JPNr.png)
On February 18, HGPI has submitted opinions (public comments) on “Basic Plan for the Promotion of Cancer Control (Draft)”to the Health Bureau of the Ministry of Health, Labour and Welfare (MHLW).
Summary of our public comments
- Recommendation 1: Genomic cancer medicine is already widely used in some types of cancer. Therefore, this should be positioned as a technology that everyone should be able to benefit from, rather than an advanced medical treatment as described in the Draft.
- Recommendation 2: As for the measures to be taken in genomic cancer medicine, one should not only focus on gathering scientific evidence, but should also emphasize to enhance medical practice guidelines, and to identify the issues and consider measures to improve access to drugs and clinical trials.
- Recommendation 3: Describe Decentralized Clinical Trials (DCTs) as one of the measures for prompt healthcare implementation, in order to provide patient-oriented and sustainable cancer care.
- Recommendation 4: In order to strengthen human resource development as a foundation to support genome cancer medicine, one should establish and strengthen cooperative relationships among hospitals with respect to specialist personnel, in addition to developing and assigning specialist personnel within the organization respectively.
- Recommendation 5: In cancer education and promotion of cancer knowledge, one should mention genome cancer medicine in addition to cancer in general.
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)